| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10787-011-0098-0 |
| P698 | PubMed publication ID | 22042237 |
| P2093 | author name string | Nicola Volpi | |
| P2860 | cites work | Dissection of a signaling pathway by which pathogen-associated molecular patterns recruit the JNK and p38 MAPKs and trigger cytokine release | Q24312954 |
| EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT) | Q24674132 | ||
| NF-kappaB at the crossroads of life and death | Q29619302 | ||
| Animal models of rheumatoid arthritis and their relevance to human disease | Q30438082 | ||
| EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). | Q33260652 | ||
| Clinical review of chondroitin sulfate in osteoarthritis | Q33357124 | ||
| Recent advances in the structural biology of chondroitin sulfate and dermatan sulfate | Q34271235 | ||
| New regulators of NF-kappaB in inflammation | Q34858737 | ||
| Glycomics: a pathway to a class of new and improved therapeutics | Q35906116 | ||
| Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control | Q36580820 | ||
| Effect of chondroitin sulphate in a rabbit model of atherosclerosis aggravated by chronic arthritis | Q36736328 | ||
| Analytical aspects of pharmaceutical grade chondroitin sulfates. | Q36881374 | ||
| Symptom and structure modifying properties of chondroitin sulfate in osteoarthritis | Q36990548 | ||
| Molecular biology of inflammation and sepsis: a primer | Q37339671 | ||
| Potential therapeutic application of chondroitin sulfate/dermatan sulfate | Q37347125 | ||
| Quality of different chondroitin sulfate preparations in relation to their therapeutic activity | Q37611121 | ||
| Antioxidant, antiinflammatory and neuroprotective actions of chondroitin sulfate and proteoglycans | Q37732930 | ||
| Modulation of inflammation by chondroitin sulfate | Q37732933 | ||
| Old and new generation lipid mediators in acute inflammation and resolution | Q37775277 | ||
| Animal models of arthritis: relevance to human disease | Q39438427 | ||
| Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: the study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial | Q39871697 | ||
| Mononuclear phagocytes and rheumatoid synovitis. Mastermind or workhorse in arthritis? | Q41329447 | ||
| Antinociceptive and anti-inflammatory activities of lectin from the marine green alga Caulerpa cupressoides | Q42987056 | ||
| Glycosaminoglycans reduced inflammatory response by modulating toll-like receptor-4 in LPS-stimulated chondrocytes | Q43267786 | ||
| Chondroitin sulfate inhibits the nuclear translocation of nuclear factor-kappaB in interleukin-1beta-stimulated chondrocytes | Q46914099 | ||
| Effects of low molecular weight chondroitin sulfate on type II collagen-induced arthritis in DBA/1J mice | Q47432573 | ||
| Effects of chondroitin sulfate-C on articular cartilage destruction in murine collagen-induced arthritis. | Q51411662 | ||
| Chondroitin sulfate inhibits lipopolysaccharide-induced inflammation in rat astrocytes by preventing nuclear factor kappa B activation | Q60688915 | ||
| Protective effect of exogenous chondroitin 4,6-sulfate in the acute degradation of articular cartilage in the rabbit | Q77320490 | ||
| Anti-inflammatory activity of chondroitin sulfate | Q77320493 | ||
| Purified human plasma glycosaminoglycans reduced NF-kappaB activation, pro-inflammatory cytokine production and apoptosis in LPS-treated chondrocytes | Q81724284 | ||
| Chondroitin sulfate effect on induced arthritis in rats | Q84872505 | ||
| P433 | issue | 6 | |
| P921 | main subject | inflammation | Q101991 |
| macromolecule | Q178593 | ||
| P304 | page(s) | 299-306 | |
| P577 | publication date | 2011-11-01 | |
| P1433 | published in | Inflammopharmacology | Q15751310 |
| P1476 | title | Anti-inflammatory activity of chondroitin sulphate: new functions from an old natural macromolecule | |
| P478 | volume | 19 |
| Q88801201 | A hyaluronic acid- and chondroitin sulfate-based medical device improves gastritis pain, discomfort, and endoscopic features |
| Q26862600 | Anti-inflammatory strategies in cartilage repair |
| Q38868544 | Anti-oxidation and Antiapoptotic Effects of Chondroitin Sulfate on 6-Hydroxydopamine-Induced Injury Through the Up-Regulation of Nrf2 and Inhibition of Mitochondria-Mediated Pathway |
| Q36808577 | Chondroitin Sulfate Immobilized on a Biomimetic Scaffold Modulates Inflammation While Driving Chondrogenesis. |
| Q64253125 | Chondroitin Sulfate Safety and Quality |
| Q34655436 | Chondroitin and glucosamine in the management of osteoarthritis: an update |
| Q46641420 | Chondroitin sulfate activates B cells in vitro, expands CD138+ cells in vivo, and interferes with established humoral immune responses |
| Q40790185 | Chondroitin sulfate prevents peritoneal fibrosis in mice by suppressing NF-κB activation |
| Q44286888 | Drugs for improving esophageal mucosa defense: where are we now and where are we going? |
| Q90636986 | Evaluation of Human Esophageal Epithelium Permeability in Presence of Different Formulations Containing Hyaluronic Acid and Chondroitin Sulphate |
| Q36409280 | Evaluation of the effect of methionine and glucosamine on adjuvant arthritis in rats |
| Q92372433 | Galactosaminoglycans: Medical Applications and Drawbacks |
| Q42094160 | Homologous overexpression of RfaH in E. coli K4 improves the production of chondroitin-like capsular polysaccharide. |
| Q39083233 | Medical application of glycosaminoglycans: a review |
| Q90015794 | Methionine attenuates the intensity of rheumatoid arthritis by downregulating NF-κB and iNOS expression in neonatal rats |
| Q90439510 | Oral Bioavailability and Pharmacokinetics of Nonanimal Chondroitin Sulfate and Its Constituents in Healthy Male Volunteers |
| Q37696562 | Randomised clinical trial: mucosal protection combined with acid suppression in the treatment of non-erosive reflux disease - efficacy of Esoxx, a hyaluronic acid-chondroitin sulphate based bioadhesive formulation. |
| Q90479612 | Regulation of Macrophage and Dendritic Cell Function by Chondroitin Sulfate in Innate to Antigen-Specific Adaptive Immunity |
| Q52863380 | Shell Cleavable Dendritic Polyglycerol Sulfates Show High Anti-Inflammatory Properties by Inhibiting L-Selectin Binding and Complement Activation. |
| Q92372703 | Sources, Extraction and Biomedical Properties of Polysaccharides |
| Q58546545 | Structure and Anti-Inflammatory Activity of a New Unusual Fucosylated Chondroitin Sulfate from |
| Q36535288 | Treatment with chondroitin sulfate to modulate inflammation and atherogenesis in obesity |
Search more.